Global Meningococcal Conjugate Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Meningococcal Conjugate market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

The Global Info Research report includes an overview of the development of the Meningococcal Conjugate industry chain, the market status of Children (Menactra, Menveo), Preteens or Teens (Menactra, Menveo), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Meningococcal Conjugate.

Regionally, the report analyzes the Meningococcal Conjugate markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Meningococcal Conjugate market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Meningococcal Conjugate market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Meningococcal Conjugate industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Menactra, Menveo).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Meningococcal Conjugate market.

Regional Analysis: The report involves examining the Meningococcal Conjugate market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Meningococcal Conjugate market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Meningococcal Conjugate:
Company Analysis: Report covers individual Meningococcal Conjugate players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Meningococcal Conjugate This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End User (Children, Preteens or Teens).

Technology Analysis: Report covers specific technologies relevant to Meningococcal Conjugate. It assesses the current state, advancements, and potential future developments in Meningococcal Conjugate areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Meningococcal Conjugate market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Meningococcal Conjugate market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of value.

Market segment by Type
    Menactra
    Menveo
    NeisVac-C
    Nimenrix
    Others

Market segment by End User
    Children
    Preteens or Teens
    Adults

Market segment by players, this report covers
    Sanofi Pasteur
    Pfizer
    Glaxo Smith Kline
    Hualan Biological Engineering
    JN International Medical Corporation
    Baxter International
    Merck
    Serum Institute of India
    Biomed
    Novartis

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Meningococcal Conjugate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Meningococcal Conjugate, with revenue, gross margin and global market share of Meningococcal Conjugate from 2019 to 2024.
Chapter 3, the Meningococcal Conjugate competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Meningococcal Conjugate market forecast, by regions, type and end user, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Meningococcal Conjugate.
Chapter 13, to describe Meningococcal Conjugate research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Meningococcal Conjugate
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Meningococcal Conjugate by Type
        1.3.1 Overview: Global Meningococcal Conjugate Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Meningococcal Conjugate Consumption Value Market Share by Type in 2023
        1.3.3 Menactra
        1.3.4 Menveo
        1.3.5 NeisVac-C
        1.3.6 Nimenrix
        1.3.7 Others
    1.4 Global Meningococcal Conjugate Market by End User
        1.4.1 Overview: Global Meningococcal Conjugate Market Size by End User: 2019 Versus 2023 Versus 2030
        1.4.2 Children
        1.4.3 Preteens or Teens
        1.4.4 Adults
    1.5 Global Meningococcal Conjugate Market Size & Forecast
    1.6 Global Meningococcal Conjugate Market Size and Forecast by Region
        1.6.1 Global Meningococcal Conjugate Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Meningococcal Conjugate Market Size by Region, (2019-2030)
        1.6.3 North America Meningococcal Conjugate Market Size and Prospect (2019-2030)
        1.6.4 Europe Meningococcal Conjugate Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Meningococcal Conjugate Market Size and Prospect (2019-2030)
        1.6.6 South America Meningococcal Conjugate Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Meningococcal Conjugate Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Sanofi Pasteur
        2.1.1 Sanofi Pasteur Details
        2.1.2 Sanofi Pasteur Major Business
        2.1.3 Sanofi Pasteur Meningococcal Conjugate Product and Solutions
        2.1.4 Sanofi Pasteur Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Sanofi Pasteur Recent Developments and Future Plans
    2.2 Pfizer
        2.2.1 Pfizer Details
        2.2.2 Pfizer Major Business
        2.2.3 Pfizer Meningococcal Conjugate Product and Solutions
        2.2.4 Pfizer Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Pfizer Recent Developments and Future Plans
    2.3 Glaxo Smith Kline
        2.3.1 Glaxo Smith Kline Details
        2.3.2 Glaxo Smith Kline Major Business
        2.3.3 Glaxo Smith Kline Meningococcal Conjugate Product and Solutions
        2.3.4 Glaxo Smith Kline Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Glaxo Smith Kline Recent Developments and Future Plans
    2.4 Hualan Biological Engineering
        2.4.1 Hualan Biological Engineering Details
        2.4.2 Hualan Biological Engineering Major Business
        2.4.3 Hualan Biological Engineering Meningococcal Conjugate Product and Solutions
        2.4.4 Hualan Biological Engineering Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Hualan Biological Engineering Recent Developments and Future Plans
    2.5 JN International Medical Corporation
        2.5.1 JN International Medical Corporation Details
        2.5.2 JN International Medical Corporation Major Business
        2.5.3 JN International Medical Corporation Meningococcal Conjugate Product and Solutions
        2.5.4 JN International Medical Corporation Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 JN International Medical Corporation Recent Developments and Future Plans
    2.6 Baxter International
        2.6.1 Baxter International Details
        2.6.2 Baxter International Major Business
        2.6.3 Baxter International Meningococcal Conjugate Product and Solutions
        2.6.4 Baxter International Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Baxter International Recent Developments and Future Plans
    2.7 Merck
        2.7.1 Merck Details
        2.7.2 Merck Major Business
        2.7.3 Merck Meningococcal Conjugate Product and Solutions
        2.7.4 Merck Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Merck Recent Developments and Future Plans
    2.8 Serum Institute of India
        2.8.1 Serum Institute of India Details
        2.8.2 Serum Institute of India Major Business
        2.8.3 Serum Institute of India Meningococcal Conjugate Product and Solutions
        2.8.4 Serum Institute of India Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Serum Institute of India Recent Developments and Future Plans
    2.9 Biomed
        2.9.1 Biomed Details
        2.9.2 Biomed Major Business
        2.9.3 Biomed Meningococcal Conjugate Product and Solutions
        2.9.4 Biomed Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Biomed Recent Developments and Future Plans
    2.10 Novartis
        2.10.1 Novartis Details
        2.10.2 Novartis Major Business
        2.10.3 Novartis Meningococcal Conjugate Product and Solutions
        2.10.4 Novartis Meningococcal Conjugate Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Novartis Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Meningococcal Conjugate Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Meningococcal Conjugate by Company Revenue
        3.2.2 Top 3 Meningococcal Conjugate Players Market Share in 2023
        3.2.3 Top 6 Meningococcal Conjugate Players Market Share in 2023
    3.3 Meningococcal Conjugate Market: Overall Company Footprint Analysis
        3.3.1 Meningococcal Conjugate Market: Region Footprint
        3.3.2 Meningococcal Conjugate Market: Company Product Type Footprint
        3.3.3 Meningococcal Conjugate Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Meningococcal Conjugate Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Meningococcal Conjugate Market Forecast by Type (2025-2030)

5 Market Size Segment by End User
    5.1 Global Meningococcal Conjugate Consumption Value Market Share by End User (2019-2024)
    5.2 Global Meningococcal Conjugate Market Forecast by End User (2025-2030)

6 North America
    6.1 North America Meningococcal Conjugate Consumption Value by Type (2019-2030)
    6.2 North America Meningococcal Conjugate Consumption Value by End User (2019-2030)
    6.3 North America Meningococcal Conjugate Market Size by Country
        6.3.1 North America Meningococcal Conjugate Consumption Value by Country (2019-2030)
        6.3.2 United States Meningococcal Conjugate Market Size and Forecast (2019-2030)
        6.3.3 Canada Meningococcal Conjugate Market Size and Forecast (2019-2030)
        6.3.4 Mexico Meningococcal Conjugate Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Meningococcal Conjugate Consumption Value by Type (2019-2030)
    7.2 Europe Meningococcal Conjugate Consumption Value by End User (2019-2030)
    7.3 Europe Meningococcal Conjugate Market Size by Country
        7.3.1 Europe Meningococcal Conjugate Consumption Value by Country (2019-2030)
        7.3.2 Germany Meningococcal Conjugate Market Size and Forecast (2019-2030)
        7.3.3 France Meningococcal Conjugate Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Meningococcal Conjugate Market Size and Forecast (2019-2030)
        7.3.5 Russia Meningococcal Conjugate Market Size and Forecast (2019-2030)
        7.3.6 Italy Meningococcal Conjugate Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Meningococcal Conjugate Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Meningococcal Conjugate Consumption Value by End User (2019-2030)
    8.3 Asia-Pacific Meningococcal Conjugate Market Size by Region
        8.3.1 Asia-Pacific Meningococcal Conjugate Consumption Value by Region (2019-2030)
        8.3.2 China Meningococcal Conjugate Market Size and Forecast (2019-2030)
        8.3.3 Japan Meningococcal Conjugate Market Size and Forecast (2019-2030)
        8.3.4 South Korea Meningococcal Conjugate Market Size and Forecast (2019-2030)
        8.3.5 India Meningococcal Conjugate Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Meningococcal Conjugate Market Size and Forecast (2019-2030)
        8.3.7 Australia Meningococcal Conjugate Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Meningococcal Conjugate Consumption Value by Type (2019-2030)
    9.2 South America Meningococcal Conjugate Consumption Value by End User (2019-2030)
    9.3 South America Meningococcal Conjugate Market Size by Country
        9.3.1 South America Meningococcal Conjugate Consumption Value by Country (2019-2030)
        9.3.2 Brazil Meningococcal Conjugate Market Size and Forecast (2019-2030)
        9.3.3 Argentina Meningococcal Conjugate Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Meningococcal Conjugate Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Meningococcal Conjugate Consumption Value by End User (2019-2030)
    10.3 Middle East & Africa Meningococcal Conjugate Market Size by Country
        10.3.1 Middle East & Africa Meningococcal Conjugate Consumption Value by Country (2019-2030)
        10.3.2 Turkey Meningococcal Conjugate Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Meningococcal Conjugate Market Size and Forecast (2019-2030)
        10.3.4 UAE Meningococcal Conjugate Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Meningococcal Conjugate Market Drivers
    11.2 Meningococcal Conjugate Market Restraints
    11.3 Meningococcal Conjugate Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Meningococcal Conjugate Industry Chain
    12.2 Meningococcal Conjugate Upstream Analysis
    12.3 Meningococcal Conjugate Midstream Analysis
    12.4 Meningococcal Conjugate Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Meningococcal Conjugate Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Meningococcal Conjugate Consumption Value by End User, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Meningococcal Conjugate Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Meningococcal Conjugate Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Sanofi Pasteur Company Information, Head Office, and Major Competitors
    Table 6. Sanofi Pasteur Major Business
    Table 7. Sanofi Pasteur Meningococcal Conjugate Product and Solutions
    Table 8. Sanofi Pasteur Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Sanofi Pasteur Recent Developments and Future Plans
    Table 10. Pfizer Company Information, Head Office, and Major Competitors
    Table 11. Pfizer Major Business
    Table 12. Pfizer Meningococcal Conjugate Product and Solutions
    Table 13. Pfizer Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Pfizer Recent Developments and Future Plans
    Table 15. Glaxo Smith Kline Company Information, Head Office, and Major Competitors
    Table 16. Glaxo Smith Kline Major Business
    Table 17. Glaxo Smith Kline Meningococcal Conjugate Product and Solutions
    Table 18. Glaxo Smith Kline Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Glaxo Smith Kline Recent Developments and Future Plans
    Table 20. Hualan Biological Engineering Company Information, Head Office, and Major Competitors
    Table 21. Hualan Biological Engineering Major Business
    Table 22. Hualan Biological Engineering Meningococcal Conjugate Product and Solutions
    Table 23. Hualan Biological Engineering Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Hualan Biological Engineering Recent Developments and Future Plans
    Table 25. JN International Medical Corporation Company Information, Head Office, and Major Competitors
    Table 26. JN International Medical Corporation Major Business
    Table 27. JN International Medical Corporation Meningococcal Conjugate Product and Solutions
    Table 28. JN International Medical Corporation Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. JN International Medical Corporation Recent Developments and Future Plans
    Table 30. Baxter International Company Information, Head Office, and Major Competitors
    Table 31. Baxter International Major Business
    Table 32. Baxter International Meningococcal Conjugate Product and Solutions
    Table 33. Baxter International Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Baxter International Recent Developments and Future Plans
    Table 35. Merck Company Information, Head Office, and Major Competitors
    Table 36. Merck Major Business
    Table 37. Merck Meningococcal Conjugate Product and Solutions
    Table 38. Merck Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Merck Recent Developments and Future Plans
    Table 40. Serum Institute of India Company Information, Head Office, and Major Competitors
    Table 41. Serum Institute of India Major Business
    Table 42. Serum Institute of India Meningococcal Conjugate Product and Solutions
    Table 43. Serum Institute of India Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Serum Institute of India Recent Developments and Future Plans
    Table 45. Biomed Company Information, Head Office, and Major Competitors
    Table 46. Biomed Major Business
    Table 47. Biomed Meningococcal Conjugate Product and Solutions
    Table 48. Biomed Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Biomed Recent Developments and Future Plans
    Table 50. Novartis Company Information, Head Office, and Major Competitors
    Table 51. Novartis Major Business
    Table 52. Novartis Meningococcal Conjugate Product and Solutions
    Table 53. Novartis Meningococcal Conjugate Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Novartis Recent Developments and Future Plans
    Table 55. Global Meningococcal Conjugate Revenue (USD Million) by Players (2019-2024)
    Table 56. Global Meningococcal Conjugate Revenue Share by Players (2019-2024)
    Table 57. Breakdown of Meningococcal Conjugate by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Meningococcal Conjugate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 59. Head Office of Key Meningococcal Conjugate Players
    Table 60. Meningococcal Conjugate Market: Company Product Type Footprint
    Table 61. Meningococcal Conjugate Market: Company Product Application Footprint
    Table 62. Meningococcal Conjugate New Market Entrants and Barriers to Market Entry
    Table 63. Meningococcal Conjugate Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Meningococcal Conjugate Consumption Value (USD Million) by Type (2019-2024)
    Table 65. Global Meningococcal Conjugate Consumption Value Share by Type (2019-2024)
    Table 66. Global Meningococcal Conjugate Consumption Value Forecast by Type (2025-2030)
    Table 67. Global Meningococcal Conjugate Consumption Value by End User (2019-2024)
    Table 68. Global Meningococcal Conjugate Consumption Value Forecast by End User (2025-2030)
    Table 69. North America Meningococcal Conjugate Consumption Value by Type (2019-2024) & (USD Million)
    Table 70. North America Meningococcal Conjugate Consumption Value by Type (2025-2030) & (USD Million)
    Table 71. North America Meningococcal Conjugate Consumption Value by End User (2019-2024) & (USD Million)
    Table 72. North America Meningococcal Conjugate Consumption Value by End User (2025-2030) & (USD Million)
    Table 73. North America Meningococcal Conjugate Consumption Value by Country (2019-2024) & (USD Million)
    Table 74. North America Meningococcal Conjugate Consumption Value by Country (2025-2030) & (USD Million)
    Table 75. Europe Meningococcal Conjugate Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Europe Meningococcal Conjugate Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Europe Meningococcal Conjugate Consumption Value by End User (2019-2024) & (USD Million)
    Table 78. Europe Meningococcal Conjugate Consumption Value by End User (2025-2030) & (USD Million)
    Table 79. Europe Meningococcal Conjugate Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Meningococcal Conjugate Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Meningococcal Conjugate Consumption Value by Type (2019-2024) & (USD Million)
    Table 82. Asia-Pacific Meningococcal Conjugate Consumption Value by Type (2025-2030) & (USD Million)
    Table 83. Asia-Pacific Meningococcal Conjugate Consumption Value by End User (2019-2024) & (USD Million)
    Table 84. Asia-Pacific Meningococcal Conjugate Consumption Value by End User (2025-2030) & (USD Million)
    Table 85. Asia-Pacific Meningococcal Conjugate Consumption Value by Region (2019-2024) & (USD Million)
    Table 86. Asia-Pacific Meningococcal Conjugate Consumption Value by Region (2025-2030) & (USD Million)
    Table 87. South America Meningococcal Conjugate Consumption Value by Type (2019-2024) & (USD Million)
    Table 88. South America Meningococcal Conjugate Consumption Value by Type (2025-2030) & (USD Million)
    Table 89. South America Meningococcal Conjugate Consumption Value by End User (2019-2024) & (USD Million)
    Table 90. South America Meningococcal Conjugate Consumption Value by End User (2025-2030) & (USD Million)
    Table 91. South America Meningococcal Conjugate Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. South America Meningococcal Conjugate Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Middle East & Africa Meningococcal Conjugate Consumption Value by Type (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Meningococcal Conjugate Consumption Value by Type (2025-2030) & (USD Million)
    Table 95. Middle East & Africa Meningococcal Conjugate Consumption Value by End User (2019-2024) & (USD Million)
    Table 96. Middle East & Africa Meningococcal Conjugate Consumption Value by End User (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Meningococcal Conjugate Consumption Value by Country (2019-2024) & (USD Million)
    Table 98. Middle East & Africa Meningococcal Conjugate Consumption Value by Country (2025-2030) & (USD Million)
    Table 99. Meningococcal Conjugate Raw Material
    Table 100. Key Suppliers of Meningococcal Conjugate Raw Materials
List of Figures
    Figure 1. Meningococcal Conjugate Picture
    Figure 2. Global Meningococcal Conjugate Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Meningococcal Conjugate Consumption Value Market Share by Type in 2023
    Figure 4. Menactra
    Figure 5. Menveo
    Figure 6. NeisVac-C
    Figure 7. Nimenrix
    Figure 8. Others
    Figure 9. Global Meningococcal Conjugate Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 10. Meningococcal Conjugate Consumption Value Market Share by End User in 2023
    Figure 11. Children Picture
    Figure 12. Preteens or Teens Picture
    Figure 13. Adults Picture
    Figure 14. Global Meningococcal Conjugate Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 15. Global Meningococcal Conjugate Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 16. Global Market Meningococcal Conjugate Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 17. Global Meningococcal Conjugate Consumption Value Market Share by Region (2019-2030)
    Figure 18. Global Meningococcal Conjugate Consumption Value Market Share by Region in 2023
    Figure 19. North America Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 20. Europe Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 21. Asia-Pacific Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 22. South America Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 23. Middle East and Africa Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 24. Global Meningococcal Conjugate Revenue Share by Players in 2023
    Figure 25. Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 26. Global Top 3 Players Meningococcal Conjugate Market Share in 2023
    Figure 27. Global Top 6 Players Meningococcal Conjugate Market Share in 2023
    Figure 28. Global Meningococcal Conjugate Consumption Value Share by Type (2019-2024)
    Figure 29. Global Meningococcal Conjugate Market Share Forecast by Type (2025-2030)
    Figure 30. Global Meningococcal Conjugate Consumption Value Share by End User (2019-2024)
    Figure 31. Global Meningococcal Conjugate Market Share Forecast by End User (2025-2030)
    Figure 32. North America Meningococcal Conjugate Consumption Value Market Share by Type (2019-2030)
    Figure 33. North America Meningococcal Conjugate Consumption Value Market Share by End User (2019-2030)
    Figure 34. North America Meningococcal Conjugate Consumption Value Market Share by Country (2019-2030)
    Figure 35. United States Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 36. Canada Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 37. Mexico Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 38. Europe Meningococcal Conjugate Consumption Value Market Share by Type (2019-2030)
    Figure 39. Europe Meningococcal Conjugate Consumption Value Market Share by End User (2019-2030)
    Figure 40. Europe Meningococcal Conjugate Consumption Value Market Share by Country (2019-2030)
    Figure 41. Germany Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 42. France Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 43. United Kingdom Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 44. Russia Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 45. Italy Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 46. Asia-Pacific Meningococcal Conjugate Consumption Value Market Share by Type (2019-2030)
    Figure 47. Asia-Pacific Meningococcal Conjugate Consumption Value Market Share by End User (2019-2030)
    Figure 48. Asia-Pacific Meningococcal Conjugate Consumption Value Market Share by Region (2019-2030)
    Figure 49. China Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 50. Japan Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 51. South Korea Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 52. India Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 53. Southeast Asia Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 54. Australia Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 55. South America Meningococcal Conjugate Consumption Value Market Share by Type (2019-2030)
    Figure 56. South America Meningococcal Conjugate Consumption Value Market Share by End User (2019-2030)
    Figure 57. South America Meningococcal Conjugate Consumption Value Market Share by Country (2019-2030)
    Figure 58. Brazil Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 59. Argentina Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 60. Middle East and Africa Meningococcal Conjugate Consumption Value Market Share by Type (2019-2030)
    Figure 61. Middle East and Africa Meningococcal Conjugate Consumption Value Market Share by End User (2019-2030)
    Figure 62. Middle East and Africa Meningococcal Conjugate Consumption Value Market Share by Country (2019-2030)
    Figure 63. Turkey Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 64. Saudi Arabia Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 65. UAE Meningococcal Conjugate Consumption Value (2019-2030) & (USD Million)
    Figure 66. Meningococcal Conjugate Market Drivers
    Figure 67. Meningococcal Conjugate Market Restraints
    Figure 68. Meningococcal Conjugate Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Meningococcal Conjugate in 2023
    Figure 71. Manufacturing Process Analysis of Meningococcal Conjugate
    Figure 72. Meningococcal Conjugate Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Companies Mentioned

Sanofi Pasteur
Pfizer
Glaxo Smith Kline
Hualan Biological Engineering
JN International Medical Corporation
Baxter International
Merck
Serum Institute of India
Biomed
Novartis